Last Updated: November 16, 2026

CLINICAL TRIALS PROFILE FOR LNP023

« Back to Dashboard


Clinical Trials for LNP023

Trial ID Title Status Sponsor Phase Summary
NCT03373461 ↗ Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation Completed Novartis Pharmaceuticals Phase 2 Efficacy and safety of LNP023 in IgAN patients
NCT03439839 ↗ Study of Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of LNP023 in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Active, not recruiting Novartis Pharmaceuticals Phase 2 The main purpose of this study is to evaluate the efficacy of LNP023 in patients with PNH, showing signs of active hemolysis despite treatment with SoC (defined as an antibody with anti C5 activity).
NCT03832114 ↗ Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted Completed Novartis Pharmaceuticals Phase 2 The study is an open-label, two cohort non-randomized study evaluating the efficacy, safety, and pharmacokinetics of LNP023 in patients with C3G (Cohort A) and patients who have undergone kidney transplant and have C3G recurrence (Cohort B).
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for LNP023

Condition Name

Condition Name
Intervention Trials
IgA Nephropathy 3
Atypical Hemolytic Uremic Syndrome 3
Paroxysmal Nocturnal Hemoglobinuria 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH
Intervention Trials
Hemoglobinuria, Paroxysmal 7
Hemoglobinuria 6
Kidney Diseases 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LNP023

Trials by Country

Trials by Country
Location Trials
Japan 32
United States 31
Spain 20
Italy 15
United Kingdom 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State
Location Trials
California 3
Ohio 3
Arizona 2
Massachusetts 2
Florida 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LNP023

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase Trials
PHASE3 1
PHASE2 1
Phase 3 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase Trials
Recruiting 11
Not yet recruiting 7
Active, not recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LNP023

Sponsor Name

Sponsor Name
Sponsor Trials
Novartis Pharmaceuticals 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type
Sponsor Trials
Industry 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.